WordNet
- the 1st letter of the Roman alphabet (同)a
- the blood group whose red cells carry the A antigen (同)type_A, group A
PrepTutorEJDIC
- answer / ampere
- arsenicの化学記号
- Virgin Islands
English Journal
- Thrombotic microangiopathy in metastatic melanoma patients treated with adoptive cell therapy and total body irradiation.
- Tseng J1, Citrin DE, Waldman M, White DE, Rosenberg SA, Yang JC.
- Cancer.Cancer.2014 May 1;120(9):1426-32. doi: 10.1002/cncr.28547. Epub 2014 Jan 28.
- BACKGROUND: Thrombotic microangiopathy (TMA) is a complication that developed in some patients receiving 12 Gy total body irradiation (TBI) in addition to lymphodepleting preparative chemotherapy prior to infusion of autologous tumor-infiltrating lymphocytes (TIL) with high-dose aldesleukin (IL-2).
- PMID 24474396
- Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation.
- Kim JH1, Stein A2, Tsai N3, Schultheiss TE1, Palmer J3, Liu A1, Rosenthal J4, Forman SJ2, Wong JY5.
- International journal of radiation oncology, biology, physics.Int J Radiat Oncol Biol Phys.2014 May 1;89(1):75-81. doi: 10.1016/j.ijrobp.2014.01.036.
- PURPOSE: Approximately 5% to 20% of patients who undergo total body irradiation (TBI) in preparation for hematopoietic cell transplantation (HCT) can develop extramedullary (EM) relapse. Whereas total marrow and lymphoid irradiation (TMLI) provides a more conformally targeted radiation therapy for p
- PMID 24725691
- Feasibility of the fludarabine busulfan 3 days and ATG 2 days reduced toxicity conditioning in 51 allogeneic hematopoietic stem cell transplantation: a single-center experience.
- Chantepie SP1, Gac AC2, Reman O2.
- Leukemia research.Leuk Res.2014 May;38(5):569-74. doi: 10.1016/j.leukres.2014.02.013. Epub 2014 Mar 3.
- In reduced-toxicity conditioning hematopoietic stem cell transplantation, several studies failed to demonstrate the superiority of one conditioning over another. This study described 51 patients (median age of 58 years) allografted with the new FB3-ATG2 conditioning regimen for myeloid (66%) or lymp
- PMID 24655805
Related Links
- Vira.cz je informačním zdrojem o křesťanské víře a životě z víry. Křesťanská víra není soubor pouček a nařízení, ale osobní vztah důvěry. Bůh důvěřuje nám a zve nás, abychom důvěřovali jemu. Křesťané věří v Boha - Lásku.
- forum Join the Word of the Day Mailing List For webmasters TheFreeDictionary Google Bing? Word / Article Starts with Ends with Text ... Vir·a-A (vîr-) A trademark for the drug vidarabine. Vira-A, trademark for an antiviral (vidarabine).
- Vira-A Generic Name: vidarabine Dosage Form: Ophthalmic OintmentFor ProfessionalsSide EffectsMore... Vira-A® (Vidarabine Ophthalmic Ointment, USP) 3% ... Vira-A Generic Name: vidarabine Dosage Form: Ophthalmic Ointment
Related Pictures
★リンクテーブル★
| リンク元 | 「ビダラビン」 |
| 関連記事 | 「A」「Ad」 |
「ビダラビン」
- 英
- vidarabine ara-a Ara-A
- 同
- アデニンアラビノシド adenine arabinoside, ARA-A, VIRA-A
- 商
- アラーゼ、アラエビン、アラセナ-A、アーメス、アラエビン、アラーゼ、カサール、シオスナール、シルベラン、ビフビン、ホスラビン
- 関
- 抗ウイルス薬、ウイルス
- 抗ウイルス剤
特徴
- 抗ウイルス薬
- DNAウイルスに有効
- プリンアナログ
- 毒性が高い
参考
- 1.
「A」